Photorefractive keratectomy (PRK) may be associated with favorable refractive outcomes in patients with moderate to high astigmatism, although eyes with greater preoperative astigmatism may have less precise correction.
Researchers retrospectively evaluated 112 eyes from 71 patients who underwent PRK between May 2018 and March 2019. The study included 69 eyes with moderate astigmatism (3.00 to 3.99 diopters [D]) and 43 eyes with high astigmatism (4.00 D or greater). All procedures used a non–wavefront-guided, aberration-free excimer laser ablation profile, with treatment planning based on manifest refraction.
The researchers assessed uncorrected distance visual acuity (UDVA), corrected distance visual acuity (CDVA), spherical equivalent, residual cylinder, and safety and efficacy indices at 1, 3, 6, and 12 months postsurgery. They also performed Alpins vector analysis to evaluate the magnitude and axis of astigmatic correction. Generalized estimating equations accounted for correlations between fellow eyes and repeated measurements, while multivariable analyses examined factors associated with residual astigmatism.
Mean cylindrical refractive error decreased from −3.76 D preoperatively to −0.73 D at 1 month, −0.72 D at 3 months, −0.58 D at 6 months, and −0.40 D at 12 months. At final follow-up, 76% of eyes achieved a spherical equivalent within 0.50 D of the intended target, while 96% were within 1.00 D. UDVA better than 20/40 was achieved in 97% of eyes. The mean efficacy and safety indices were 0.92 and 0.99, respectively.
Astigmatic correction differed according to baseline severity. At 12 months, 64% of eyes with moderate astigmatism achieved residual cylinder of 0.50 D or less vs. 28% of eyes with high astigmatism. Residual astigmatism exceeding 1.00 D occurred in 7% and 30% of eyes, respectively.
The mean difference vector, representing residual astigmatic correction error, was 0.59 D in the moderate group vs. 0.97 D in the high group. The surgically induced astigmatism vector was greater in the high group, at 4.66 D vs. 3.14 D. The overall correction index was 1.07, suggesting a slight tendency toward overcorrection in astigmatic magnitude. Angular accuracy remained favorable, with 71% of eyes achieving an angle of error within 5 degrees and 100% within 15 degrees.
In multivariable analyses, higher preoperative cylinder and poorer preoperative CDVA were independently associated with greater residual astigmatism. Preoperative spherical refractive error was not independently associated with the outcome. Longer mitomycin C application time was associated with greater residual astigmatism, although the researchers cautioned that this finding likely reflected confounding by indication. Eyes requiring larger refractive corrections received longer mitomycin C exposure, limiting conclusions about an independent effect of application duration.
The study had several limitations, including its retrospective, single-center design, relatively small sample, and absence of a control group. Although statistical analyses accounted for correlations between fellow eyes, 41 patients contributed both eyes. The 12-month follow-up period also limited assessment of long-term refractive stability because astigmatic regression may occur beyond the first postoperative year. Additionally, the observational design and treatment-dependent mitomycin C exposure prevented causal conclusions regarding factors associated with residual astigmatism.
“Higher preoperative cylinder and poorer baseline visual acuity were associated with greater residual astigmatism,” wrote lead study author Amir Reza Farsiani, of Zanjan University of Medical Sciences in Iran, and colleagues.
The study authors reported no conflicts of interest.
Source: Clinical Optometry
